PT  - JOURNAL ARTICLE
AU  - Li, Jiatao
AU  - Liu, Shimeng
TI  - Role of Thromboinflammation Interaction in the Serious-Critical COVID-19 Pneumonia: A Single-center Retrospective Study
AID  - 10.1101/2024.04.19.24306109
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.04.19.24306109
4099  - http://medrxiv.org/content/early/2024/04/20/2024.04.19.24306109.short
4100  - http://medrxiv.org/content/early/2024/04/20/2024.04.19.24306109.full
AB  - Aim To describe the potential role of thromboinflammation in thromboembolism and the progress of coronavirus disease 2019 (COVID-19).Methods The retrospective study included sequentially hospitalized patients with the diagnosis of COVID-19 pneumonia during the first pandemic (December 1, 2022, to January 31, 2023) at a medical center in Beijing, China. Risks of critical medical support requirements, thrombosis events, and death were valued in the multivariate logistic regression models, where age (≥ 80 vs. < 80 years old), nadir platelets level (≤100 vs. > 100 10^9/L), C-reactive protein (CRP) level at admission (≥ 80 vs. < 80 mg/L), D-dimer level at admission (≥ 1.0 vs. < 1.0 mg/L) were dichotomized.Results A total of 88 patients were included (median age 77 years, 72% male). During hospitalization, 35 (40%) patients required critical medical support, 22 (29%) had disseminated intravascular coagulation (DIC), 11 (13%) had radiologically supported thrombosis events, and 26 (30%) died. Increased age (odds ratio [OR]: 5.22,95% confidence interval [CI]: 1.27-21.53; p=0.02), elevated CRP levels (OR: 9.26, 95% CI: 2.24-38.37; p<0.01), decreased nadir platelet level (OR: 13.47, 95% CI: 1.91-94.84; p<0.01), elevated D-dimer level (OR: 5.21, 95 CI%: 0.96-28.21; p=0.06) were associated with the requirements of critical care. Increased age (OR: 10.87, 95% CI: 3.05-38.80; p<0.01), elevated CRP levels (OR: 6.14, 95% CI:1.68-22.47; p<0.01), decreased nadir platelet levels (OR: 5.96, 95% CI: 1.34-26.47; p=0.02) and D-dimers (≥1.0 vs. <1.0 mg/L, OR: 2.26, 95% CI: 0.68-7.44; p=0.18) were associated with death. Increased age (OR: 2.40,95% CI: 0.60-9.67; p=0.22), decreased nadir platelet levels (OR: 1.31, 95% CI: 0.22-7.96; p=0.77), inflmmation status, including D-dimers (≥1.0 vs. <1.0 mg/L, OR:4.62, 95% CI: 0.89-24.04; p=0.07) and CRP (≥80 vs. <80 mg/mL, OR:5.44, 95% CI: 1.05-28.27; p=0.04) were significantly associated with the risks of thromboembolism.Conclusions The retrospective study indicated thromboinflammation promoted thromboembolism and was associated with the outcomes of COVID-19 pneumonia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Natural Science Foundation of China under Grant [82001242].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the IRB of Beijing Tiantan Hospital, Capital Medical University.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes